Clinical Validation of a Circulating Tumor Cell Assay Using Density Centrifugation and Automated Immunofluorescence Microscopy.

Daniel E SabathMarie E PerroneAlisa CleinMichael TamMichael HardinSara TrimbleArturo RamirezMelinda DuplessisTanisha MojicaCelestia S HiganoV K GadiEric KaldjianTad George

Published in: American journal of clinical pathology (2022)

The RareCyte CTC assay has comparable performance to the FDA-cleared method and is ready for further clinical validation studies.

Keyphrases

high throughput
circulating tumor
circulating tumor cells
single cell
machine learning
high resolution
cell therapy
cell free
mesenchymal stem cells
high speed
mass spectrometry
bone marrow
label free